Treatment of Shortness of breath

Reading File

Finding Sources

Searching PubMed

"dyspnea" AND "treatment" AND "management"

Reading File

I now have comprehensive textbook content from multiple authoritative sources. Let me compile the full answer.

Treatment of Shortness of Breath (Dyspnea)

Dyspnea is defined as "a subjective experience of breathing discomfort that consists of qualitatively distinct sensations that vary in intensity." It is one of the most common presenting complaints in medicine, affecting up to 25% of middle-aged and older adults and 49% of critically ill patients. Treatment is always two-pronged: (1) treat the underlying cause, and (2) manage the symptom when full relief from treating the cause is not possible.

Step 1 - Identify and Treat the Underlying Cause

The first and most important goal is to identify and correct the condition driving dyspnea. Common causes include:

Category	Conditions
Cardiac	Heart failure, myocardial ischemia, pericardial tamponade, valvular disease
Pulmonary	COPD, asthma, pneumonia, pulmonary embolism, pneumothorax, pleural effusion, interstitial lung disease
Infectious	Acute bronchitis, pneumonia, epiglottitis
Hematologic	Severe anemia
Metabolic	Diabetic ketoacidosis, lactic acidosis (Kussmaul breathing)
Neuromuscular	Guillain-Barre, myasthenia gravis, diaphragmatic paralysis
Toxic/Drug	Salicylate overdose, toxic inhalations
Anxiety/Psychogenic	Hyperventilation syndrome, sighing syndrome

Acute dyspnea requires urgent evaluation with vital signs, oximetry, chest X-ray, ECG, and targeted labs (ABG, BNP, D-dimer, CBC).

Step 2 - Specific Treatments by Mechanism

Murray & Nadel's Textbook of Respiratory Medicine organizes symptomatic treatment by the quality of the dyspnea and its underlying physiology (Table 36.3):

Quality of Dyspnea	Physiology	Treatment
Air hunger / urge to breathe	Chemoreceptor stimulation	Supplemental O₂, nasal gas flow, cool air on face, opioids
Chest tightness	Airway receptor stimulation	Inhaled bronchodilators (β-agonists, anticholinergics, steroids)
Cannot get a deep breath	Dynamic hyperinflation	Pursed-lip breathing, slow breathing retraining
Increased work/effort to breathe	Mechanical load or neuromuscular weakness	Inspiratory muscle training, non-invasive ventilation (BiPAP)
Feeling of rapid/heavy breathing	Deconditioning, metaboreceptors	Exercise training / pulmonary rehabilitation
All qualities	Altered central perception	Pulmonary rehab desensitization, morphine

Step 3 - Non-Pharmacologic Treatments

Supplemental Oxygen

Indicated when resting SpO₂ is <88% or drops to this level with activity or sleep.
In COPD patients with hypoxemia, supplemental O₂ improves mortality.
For non-hypoxemic patients, evidence of benefit is limited - a meta-analysis found no consistent symptomatic benefit from oxygen alone (Miller's Anesthesia, 10e).

Pulmonary Rehabilitation

Combines exercise training, education, and breathing retraining.
Reduces dyspnea, increases exercise capacity, and improves quality of life in COPD and other chronic respiratory diseases.
Also shown to improve outcomes in post-COVID conditions.
Yoga and Tai Chi are mind-body adjuncts with positive effects on dyspnea in obstructive lung diseases.

Breathing Techniques

Pursed-lip breathing: slows and prolongs exhalation, reduces dynamic hyperinflation in COPD.
Breathing retraining: slowing respiratory rate can relieve the sensation of inability to take a deep breath.
A 2024 systematic review (Burge et al., Eur Respir Rev 2024 - PMID 39477355) confirmed benefit of breathing techniques in serious respiratory illness.

Fan / Cool Air on the Face

Blowing cool air via a fan activates facial receptors innervated by the trigeminal nerve, which can reduce the drive to breathe and relieve the sensation of air hunger. Simple and underused.

Non-Invasive Ventilation (NIV / BiPAP)

Provides inspiratory muscle support, reduces work of breathing and muscle fatigue.
Used extensively for acute dyspnea in the ED and ICU.
A 2024 meta-analysis (PMID 39166964) compared high-flow nasal cannula (HFNC) vs. NIV in acute heart failure - both are effective options for acute respiratory failure.

Thoracentesis / Pleural Procedures

For dyspnea due to large pleural effusion or pneumothorax, drainage (thoracentesis, chest drain) directly relieves the dyspnea by removing the mechanical constraint.

Step 4 - Pharmacologic Treatments for Symptom Management

Opioids

The most evidence-backed drug class for refractory dyspnea when the cause cannot be fully treated.

Morphine (low dose) reduces air hunger largely by suppressing respiratory drive and influencing cortical activity.
A crossover RCT in 48 COPD patients showed 20 mg sustained-release morphine daily produced significant improvement in dyspnea with minimal side effects.
A 2024 meta-analysis (Smallwood et al., Eur Respir Rev 2024 - PMID 39384304) confirmed safety and efficacy of opioids for palliation of symptoms in serious respiratory illness.
Caution: A recent RCT (BEAMS trial, JAMA 2022) did not support benefit of low-dose extended-release morphine in COPD broadly - so opioids should be individualized based on the risk-benefit profile for respiratory depression.
Acutely, small doses of opioids in COPD/asthma exacerbations can break the tachypnea → dynamic hyperinflation → more dyspnea → more anxiety cycle, buying time for bronchodilators to work.
In interstitial lung disease, opioid use was not associated with increased hospitalization or mortality.

Bronchodilators (for Obstructive Lung Disease)

Short-acting β₂-agonists (salbutamol/albuterol): first-line for acute asthma and COPD exacerbation.
Short-acting anticholinergics (ipratropium): additive effect with β₂-agonists.
Long-acting bronchodilators (LABAs, LAMAs): for chronic COPD management to reduce daily dyspnea.
Inhaled corticosteroids: for eosinophilic COPD and asthma.
A 2025 meta-analysis (PMID 39557208) reviewed ensifentrine (dual PDE3/PDE4 inhibitor, a newer agent) for COPD, showing safety and efficacy.

Diuretics

For heart failure with pulmonary congestion: IV furosemide reduces preload, improves dyspnea rapidly.
Inhaled furosemide has also been studied to activate slowly-adapting stretch receptors in the lung, with mixed results - may benefit a subgroup of patients.

Corticosteroids

Systemic steroids for acute asthma exacerbation and COPD exacerbation.
Glucocorticoids may benefit some forms of interstitial lung disease (e.g., hypersensitivity pneumonitis, drug-induced).

Anxiolytics

Formal studies of anxiolytics (benzodiazepines) for dyspnea have failed to show consistent benefit.
Small studies show a trend toward possible benefit when combined with opioids.
May be appropriate for hyperventilation/sighing syndrome alongside cognitive behavioral therapy.

Antibiotics

For dyspnea due to pneumonia, acute bronchitis, or infective COPD exacerbations.

Step 5 - Dyspnea in Special Situations

Acute/Emergency Setting

In acute presentations, the priority sequence is:

Airway - secure if obstructed
Supplemental O₂ - titrate to SpO₂ ≥ 94% (88-92% in COPD)
Position - upright sitting (tripod position if needed)
HFNC or NIV - for hypoxemic/hypercapnic respiratory failure
Disease-specific Rx - bronchodilators (asthma/COPD), diuretics (CHF), heparin/thrombolytics (PE), antibiotics (pneumonia)

End-Stage / Palliative Setting

When dyspnea is refractory and goals shift toward comfort, opioids are the mainstay of pharmacologic palliation.
Coordination between pulmonology and palliative care improves breathlessness mastery and even prolongs survival.
Fan, positioning, and psychological support remain important non-pharmacologic measures.
"Chronic breathlessness syndrome" (defined 2017) is the entity of breathlessness persisting despite optimal treatment of underlying pathophysiology.

Summary Table

Treatment	Evidence Strength	Best For
Treat underlying cause	Strongest	All dyspnea
Supplemental O₂ (if SpO₂ <88%)	Strong	Hypoxemic patients
Short-acting bronchodilators	Strong	Asthma, COPD
IV Diuretics	Strong	Heart failure
NIV/BiPAP	Strong	Acute hypercapnic/hypoxemic failure
Pulmonary rehabilitation	Strong	Chronic COPD, post-COVID
Low-dose opioids	Moderate	Refractory/palliative dyspnea
Fan/cool air	Moderate	Any dyspnea - simple adjunct
Pursed-lip/breathing retraining	Moderate	COPD, hyperventilation
Anxiolytics	Weak	Hyperventilation, anxiety-driven
Inhaled furosemide	Weak/mixed	Subgroup of patients

Sources:

Harrison's Principles of Internal Medicine, 22nd ed. (2025), p. 314-315
Murray & Nadel's Textbook of Respiratory Medicine, 2-Volume, pp. 861-863
Miller's Anesthesia, 10th ed., p. 6993
Goldman-Cecil Medicine, International Edition
Smallwood et al. Opioids for palliation in serious respiratory illness. Eur Respir Rev 2024. PMID 39384304
Burge et al. Breathing techniques in serious respiratory illness. Eur Respir Rev 2024. PMID 39477355
Marjanovic et al. HFNC vs. NIV in acute heart failure. Eur J Emerg Med 2024. PMID 39166964

Can,you make slides

Reading File

Running Command

mkdir -p /home/daytona/workspace/dyspnea-slides && ls /home/daytona/workspace/dy…

Writing File

~/dyspnea-slides/create_slides.js

const pptxgen = require("pptxgenjs");

const pres = new pptxgen();
pres.layout = "LAYOUT_16x9";
pres.title = "Treatment of Shortness of Breath (Dyspnea)";
pres.author = "Orris Medical";

// ─── COLOR PALETTE ───────────────────────────────────────────────────
// Deep teal/navy medical theme
const C = {
  navy:     "0D2B4E",   // dominant dark (title slides, headers)
  teal:     "0E7C7B",   // supporting accent
  sky:      "4ABCD9",   // highlight / bullets
  white:    "FFFFFF",
  offWhite: "F4F8FB",
  light:    "D6EAF0",
  mid:      "B0CDD8",
  text:     "1A2E3C",
  sub:      "4A6274",
  red:      "C0392B",
  amber:    "E67E22",
  green:    "27AE60",
};

// ─── HELPERS ─────────────────────────────────────────────────────────
function darkSlide(slide) {
  slide.addShape(pres.ShapeType.rect, { x: 0, y: 0, w: 10, h: 5.625, fill: { color: C.navy }, line: { color: C.navy } });
}
function lightSlide(slide) {
  slide.addShape(pres.ShapeType.rect, { x: 0, y: 0, w: 10, h: 5.625, fill: { color: C.offWhite }, line: { color: C.offWhite } });
}
function accentBar(slide, y, h = 0.06) {
  slide.addShape(pres.ShapeType.rect, { x: 0, y, w: 10, h, fill: { color: C.teal }, line: { color: C.teal } });
}
function sectionHeader(slide, text, y = 0.28) {
  slide.addText(text, {
    x: 0.5, y, w: 9, h: 0.45,
    fontSize: 13, bold: true, color: C.teal,
    fontFace: "Calibri", margin: 0, charSpacing: 1.5,
  });
}
function bodyTitle(slide, text, y = 0.18) {
  slide.addText(text, {
    x: 0.5, y, w: 9, h: 0.6,
    fontSize: 22, bold: true, color: C.navy,
    fontFace: "Calibri", margin: 0,
  });
}
function divider(slide, y) {
  slide.addShape(pres.ShapeType.rect, { x: 0.5, y, w: 0.5, h: 0.05, fill: { color: C.sky }, line: { color: C.sky } });
}
function footerNote(slide, text) {
  slide.addText(text, {
    x: 0.3, y: 5.22, w: 9.4, h: 0.3,
    fontSize: 7.5, color: C.sub, fontFace: "Calibri", italic: true, margin: 0,
  });
}
function slideNum(slide, n) {
  slide.addText(`${n}`, {
    x: 9.5, y: 5.2, w: 0.4, h: 0.3,
    fontSize: 8, color: C.sub, align: "right", margin: 0,
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 1 - TITLE
// ═══════════════════════════════════════════════════════════════════
{
  const s = pres.addSlide();
  darkSlide(s);

  // Teal accent stripe left
  s.addShape(pres.ShapeType.rect, { x: 0, y: 0, w: 0.18, h: 5.625, fill: { color: C.teal }, line: { color: C.teal } });

  // Decorative bottom bar
  s.addShape(pres.ShapeType.rect, { x: 0, y: 5.2, w: 10, h: 0.425, fill: { color: C.teal }, line: { color: C.teal } });

  s.addText("TREATMENT OF", {
    x: 0.5, y: 1.1, w: 9, h: 0.55,
    fontSize: 18, bold: false, color: C.sky, fontFace: "Calibri",
    charSpacing: 4, margin: 0,
  });
  s.addText("Shortness of Breath", {
    x: 0.5, y: 1.65, w: 9, h: 1.1,
    fontSize: 44, bold: true, color: C.white, fontFace: "Calibri", margin: 0,
  });
  s.addText("(Dyspnea)", {
    x: 0.5, y: 2.75, w: 9, h: 0.6,
    fontSize: 26, bold: false, color: C.mid, fontFace: "Calibri", italic: true, margin: 0,
  });
  s.addText("Mechanisms · Diagnosis · Pharmacologic & Non-Pharmacologic Management · Palliative Care", {
    x: 0.5, y: 3.55, w: 9, h: 0.45,
    fontSize: 11, color: C.mid, fontFace: "Calibri", margin: 0,
  });
  s.addText("Based on Harrison's 22e · Murray & Nadel's · Goldman-Cecil Medicine · Miller's Anesthesia", {
    x: 0.3, y: 5.27, w: 9.4, h: 0.25,
    fontSize: 8, color: C.white, fontFace: "Calibri", margin: 0,
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 2 - WHAT IS DYSPNEA?
// ═══════════════════════════════════════════════════════════════════
{
  const s = pres.addSlide();
  lightSlide(s);
  accentBar(s, 0, 0.09);

  bodyTitle(s, "What is Dyspnea?");
  divider(s, 0.82);

  // Definition box
  s.addShape(pres.ShapeType.rect, {
    x: 0.5, y: 0.95, w: 9, h: 0.85,
    fill: { color: C.navy }, line: { color: C.navy },
    shadow: { type: "outer", color: "000000", blur: 6, offset: 2, angle: 135, opacity: 0.12 },
  });
  s.addText('"A subjective experience of breathing discomfort that consists of qualitatively distinct sensations that vary in intensity"', {
    x: 0.6, y: 0.97, w: 8.8, h: 0.8,
    fontSize: 12, color: C.light, fontFace: "Calibri", italic: true, valign: "middle", margin: 6,
  });
  s.addText("— American Thoracic Society", {
    x: 0.6, y: 1.75, w: 8.8, h: 0.25,
    fontSize: 9, color: C.sky, fontFace: "Calibri", align: "right", margin: 0,
  });

  // Stats row
  const stats = [
    { val: "25%", label: "of middle-aged & older adults" },
    { val: "16%", label: "of non-critical hospital admissions" },
    { val: "49%", label: "of critically ill patients" },
  ];
  stats.forEach((st, i) => {
    const x = 0.5 + i * 3.1;
    s.addShape(pres.ShapeType.rect, {
      x, y: 2.12, w: 2.85, h: 1.1,
      fill: { color: C.light }, line: { color: C.mid },
    });
    s.addText(st.val, { x, y: 2.18, w: 2.85, h: 0.55, fontSize: 28, bold: true, color: C.teal, align: "center", valign: "middle", margin: 0 });
    s.addText(st.label, { x, y: 2.73, w: 2.85, h: 0.42, fontSize: 9, color: C.sub, align: "center", margin: 0 });
  });

  // Four mechanisms
  s.addText("FOUR PHYSIOLOGIC ORIGINS", { x: 0.5, y: 3.33, w: 9, h: 0.28, fontSize: 9.5, bold: true, color: C.teal, charSpacing: 1.5, margin: 0 });
  const mechs = [
    "Hypoxemia / Hypercapnia → chemoreceptor stimulation",
    "Stimulation of sensory receptors in airways, lungs, chest wall",
    "Mechanical load on respiratory system (↑resistance, ↓compliance)",
    "Neuromuscular weakness — unable to handle even normal loads",
  ];
  s.addText(
    mechs.map((m, i) => ({ text: `${i+1}.  ${m}`, options: { bullet: false, breakLine: i < mechs.length-1 } })),
    { x: 0.5, y: 3.63, w: 9.2, h: 1.45, fontSize: 11, color: C.text, fontFace: "Calibri", lineSpacingMultiple: 1.35 }
  );

  footerNote(s, "Murray & Nadel's Textbook of Respiratory Medicine | Goldman-Cecil Medicine");
  slideNum(s, 2);
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 3 - COMMON CAUSES
// ═══════════════════════════════════════════════════════════════════
{
  const s = pres.addSlide();
  lightSlide(s);
  accentBar(s, 0, 0.09);

  bodyTitle(s, "Common Causes of Dyspnea");
  divider(s, 0.82);

  const categories = [
    { cat: "CARDIAC", color: C.red, items: ["Heart failure (LVF/RVF)", "Myocardial ischemia/MI", "Pericardial tamponade", "Valvular disease"] },
    { cat: "PULMONARY", color: C.teal, items: ["COPD / Asthma", "Pulmonary embolism", "Pneumothorax", "Interstitial lung disease"] },
    { cat: "INFECTIVE", color: C.amber, items: ["Pneumonia", "Acute bronchitis", "Epiglottitis / croup", "Sepsis"] },
    { cat: "OTHER", color: C.sky, items: ["Severe anemia", "DKA / metabolic acidosis", "Neuromuscular disease", "Anxiety / hyperventilation"] },
  ];

  categories.forEach((cat, i) => {
    const col = i % 2;
    const row = Math.floor(i / 2);
    const x = 0.35 + col * 4.85;
    const y = 0.98 + row * 2.15;

    s.addShape(pres.ShapeType.rect, {
      x, y, w: 4.55, h: 2.0,
      fill: { color: C.white },
      line: { color: C.mid, pt: 1 },
      shadow: { type: "outer", color: "000000", blur: 4, offset: 1, angle: 135, opacity: 0.08 },
    });
    // Cat header
    s.addShape(pres.ShapeType.rect, { x, y, w: 4.55, h: 0.38, fill: { color: cat.color }, line: { color: cat.color } });
    s.addText(cat.cat, { x: x+0.12, y: y+0.03, w: 4.3, h: 0.33, fontSize: 10.5, bold: true, color: C.white, charSpacing: 1.5, valign: "middle", margin: 0 });
    s.addText(
      cat.items.map((item, j) => ({ text: `• ${item}`, options: { breakLine: j < cat.items.length-1 } })),
      { x: x+0.15, y: y+0.43, w: 4.25, h: 1.5, fontSize: 10.5, color: C.text, lineSpacingMultiple: 1.35 }
    );
  });

  footerNote(s, "Goldman-Cecil Medicine | Harrison's Principles of Internal Medicine 22e");
  slideNum(s, 3);
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 4 - DIAGNOSTIC APPROACH
// ═══════════════════════════════════════════════════════════════════
{
  const s = pres.addSlide();
  lightSlide(s);
  accentBar(s, 0, 0.09);

  bodyTitle(s, "Diagnostic Approach");
  divider(s, 0.82);

  // Arrow/flow steps
  const steps = [
    { n: "1", title: "History & Vitals", detail: "Onset (acute vs chronic) · Orthopnea · PND · SpO₂ · RR · Pulsus paradoxus" },
    { n: "2", title: "Physical Exam", detail: "Accessory muscle use · Tripod position · Auscultation (wheeze, crackles, rales) · JVD · Edema" },
    { n: "3", title: "Investigations", detail: "ECG · CXR · ABG · CBC · BNP · D-dimer · Spirometry · Echocardiogram · HRCT" },
    { n: "4", title: "Identify Cause", detail: "Obstructive? Restrictive? Cardiac? Vascular? Neuromuscular? Psychogenic?" },
  ];

  steps.forEach((step, i) => {
    const y = 0.97 + i * 1.07;
    // Number circle
    s.addShape(pres.ShapeType.ellipse, { x: 0.38, y: y+0.05, w: 0.45, h: 0.45, fill: { color: C.teal }, line: { color: C.teal } });
    s.addText(step.n, { x: 0.38, y: y+0.05, w: 0.45, h: 0.45, fontSize: 14, bold: true, color: C.white, align: "center", valign: "middle", margin: 0 });
    // Connector line
    if (i < steps.length - 1) {
      s.addShape(pres.ShapeType.rect, { x: 0.57, y: y+0.5, w: 0.07, h: 0.64, fill: { color: C.mid }, line: { color: C.mid } });
    }
    // Content box
    s.addShape(pres.ShapeType.rect, {
      x: 1.0, y, w: 8.7, h: 0.9,
      fill: { color: C.white }, line: { color: C.mid, pt: 1 },
    });
    s.addText(step.title, { x: 1.15, y: y+0.05, w: 3.5, h: 0.38, fontSize: 13, bold: true, color: C.navy, margin: 0 });
    s.addText(step.detail, { x: 1.15, y: y+0.43, w: 8.4, h: 0.4, fontSize: 10, color: C.sub, margin: 0 });
  });

  s.addText("SpO₂ < 88% at rest or with activity → supplemental oxygen indicated", {
    x: 1.0, y: 5.08, w: 8.7, h: 0.28,
    fontSize: 10, bold: true, color: C.red, margin: 0,
  });

  footerNote(s, "Harrison's Principles of Internal Medicine 22e | Murray & Nadel's");
  slideNum(s, 4);
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 5 - TREATMENT OVERVIEW (TWO GOALS)
// ═══════════════════════════════════════════════════════════════════
{
  const s = pres.addSlide();
  darkSlide(s);

  s.addShape(pres.ShapeType.rect, { x: 0, y: 5.2, w: 10, h: 0.425, fill: { color: C.teal }, line: { color: C.teal } });

  s.addText("TREATMENT FRAMEWORK", {
    x: 0.5, y: 0.2, w: 9, h: 0.45,
    fontSize: 13, bold: true, color: C.sky, charSpacing: 3, margin: 0,
  });
  s.addText("Two Essential Goals", {
    x: 0.5, y: 0.65, w: 9, h: 0.7,
    fontSize: 32, bold: true, color: C.white, margin: 0,
  });

  // Goal 1
  s.addShape(pres.ShapeType.rect, { x: 0.4, y: 1.55, w: 4.35, h: 3.35, fill: { color: "0A2540" }, line: { color: C.teal, pt: 2 } });
  s.addShape(pres.ShapeType.rect, { x: 0.4, y: 1.55, w: 4.35, h: 0.42, fill: { color: C.teal }, line: { color: C.teal } });
  s.addText("GOAL 1", { x: 0.5, y: 1.57, w: 4.1, h: 0.38, fontSize: 11, bold: true, color: C.white, charSpacing: 2, margin: 0 });
  s.addText("Treat the\nUnderlying Cause", { x: 0.5, y: 2.02, w: 4.1, h: 0.9, fontSize: 19, bold: true, color: C.sky, lineSpacingMultiple: 1.2, margin: 0 });
  s.addText([
    { text: "• Bronchodilators → asthma/COPD\n", options: {} },
    { text: "• Diuretics → heart failure\n", options: {} },
    { text: "• Antibiotics → pneumonia\n", options: {} },
    { text: "• Thoracentesis → pleural effusion\n", options: {} },
    { text: "• Anticoagulation → pulmonary embolism", options: {} },
  ], { x: 0.55, y: 2.97, w: 4.1, h: 1.85, fontSize: 10.5, color: C.mid, lineSpacingMultiple: 1.35 });

  // Goal 2
  s.addShape(pres.ShapeType.rect, { x: 5.25, y: 1.55, w: 4.35, h: 3.35, fill: { color: "0A2540" }, line: { color: C.sky, pt: 2 } });
  s.addShape(pres.ShapeType.rect, { x: 5.25, y: 1.55, w: 4.35, h: 0.42, fill: { color: C.sky }, line: { color: C.sky } });
  s.addText("GOAL 2", { x: 5.35, y: 1.57, w: 4.1, h: 0.38, fontSize: 11, bold: true, color: C.navy, charSpacing: 2, margin: 0 });
  s.addText("Relieve the\nSymptom", { x: 5.35, y: 2.02, w: 4.1, h: 0.9, fontSize: 19, bold: true, color: C.white, lineSpacingMultiple: 1.2, margin: 0 });
  s.addText([
    { text: "When full cause reversal is not possible:\n", options: { italic: true } },
    { text: "• Opioids for refractory dyspnea\n", options: {} },
    { text: "• Supplemental O₂ if SpO₂ < 88%\n", options: {} },
    { text: "• Pulmonary rehabilitation\n", options: {} },
    { text: "• Non-pharmacologic measures", options: {} },
  ], { x: 5.4, y: 2.97, w: 4.1, h: 1.85, fontSize: 10.5, color: C.mid, lineSpacingMultiple: 1.35 });

  s.addText("Harrison's 22e: \"Chronic breathlessness syndrome = breathlessness persisting despite optimal treatment of underlying pathophysiology\"", {
    x: 0.3, y: 5.23, w: 9.4, h: 0.25,
    fontSize: 7.5, color: C.white, italic: true, margin: 0,
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 6 - NON-PHARMACOLOGIC TREATMENTS
// ═══════════════════════════════════════════════════════════════════
{
  const s = pres.addSlide();
  lightSlide(s);
  accentBar(s, 0, 0.09);

  bodyTitle(s, "Non-Pharmacologic Treatments");
  divider(s, 0.82);

  const cards = [
    {
      title: "Supplemental Oxygen",
      color: C.sky,
      points: ["Indicated when SpO₂ < 88% at rest or with activity", "Improves mortality in hypoxemic COPD patients", "Nasal flow also activates nose receptors → ↓ respiratory drive"],
    },
    {
      title: "Pulmonary Rehabilitation",
      color: C.teal,
      points: ["Exercise + education + breathing retraining", "↓ dyspnea · ↑ exercise capacity · ↑ quality of life", "Desensitizes patients to breathing discomfort", "Yoga & Tai Chi: adjuncts for obstructive lung disease"],
    },
    {
      title: "Breathing Techniques",
      color: C.navy,
      points: ["Pursed-lip breathing → ↓ dynamic hyperinflation in COPD", "Slow breathing retraining → relieves 'can't get deep breath'", "Diaphragmatic breathing and respiratory biofeedback"],
    },
    {
      title: "Fan / Cool Air on Face",
      color: C.amber,
      points: ["Activates facial receptors via trigeminal nerve", "Reduces central drive to breathe", "Simple, non-invasive, underused in clinical practice"],
    },
    {
      title: "NIV / BiPAP",
      color: C.red,
      points: ["Provides inspiratory muscle support", "Reduces work of breathing and muscle fatigue", "Standard of care in acute hypercapnic respiratory failure"],
    },
    {
      title: "Pleural/Procedural Relief",
      color: C.sub,
      points: ["Thoracentesis for pleural effusion", "Chest drain for pneumothorax", "Direct mechanical relief of dyspnea"],
    },
  ];

  cards.forEach((card, i) => {
    const col = i % 3;
    const row = Math.floor(i / 3);
    const x = 0.25 + col * 3.22;
    const y = 0.97 + row * 2.22;

    s.addShape(pres.ShapeType.rect, {
      x, y, w: 3.1, h: 2.1,
      fill: { color: C.white }, line: { color: C.mid, pt: 1 },
      shadow: { type: "outer", color: "000000", blur: 5, offset: 2, angle: 135, opacity: 0.09 },
    });
    s.addShape(pres.ShapeType.rect, { x, y, w: 3.1, h: 0.38, fill: { color: card.color }, line: { color: card.color } });
    s.addText(card.title, { x: x+0.1, y: y+0.04, w: 2.9, h: 0.32, fontSize: 10, bold: true, color: C.white, valign: "middle", margin: 0 });
    s.addText(
      card.points.map((p, j) => ({ text: `• ${p}`, options: { breakLine: j < card.points.length-1 } })),
      { x: x+0.1, y: y+0.43, w: 2.9, h: 1.6, fontSize: 9.5, color: C.text, lineSpacingMultiple: 1.3 }
    );
  });

  footerNote(s, "Murray & Nadel's | Miller's Anesthesia 10e | Burge et al. Eur Respir Rev 2024 (PMID 39477355)");
  slideNum(s, 6);
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 7 - PHARMACOLOGIC TREATMENTS
// ═══════════════════════════════════════════════════════════════════
{
  const s = pres.addSlide();
  lightSlide(s);
  accentBar(s, 0, 0.09);

  bodyTitle(s, "Pharmacologic Treatments");
  divider(s, 0.82);

  const drugs = [
    { drug: "Short-acting Bronchodilators", sub: "(Salbutamol, Ipratropium)", color: C.teal, use: "First-line for acute asthma & COPD exacerbation", note: "SABA + SAMA combination more effective than either alone" },
    { drug: "Long-acting Bronchodilators", sub: "(LABAs, LAMAs)", color: C.teal, use: "Chronic COPD — reduce daily dyspnea & exacerbations", note: "Cornerstone of GOLD-guided COPD management" },
    { drug: "IV / Oral Diuretics", sub: "(Furosemide, Spironolactone)", color: C.sky, use: "Heart failure with pulmonary congestion", note: "IV furosemide for acute decompensated HF; rapid relief" },
    { drug: "Systemic Corticosteroids", sub: "(Prednisolone, Methylprednisolone)", color: C.amber, use: "Acute asthma, COPD exacerbation, some ILD", note: "Short courses; avoid chronic use in COPD" },
    { drug: "Opioids (Low Dose)", sub: "(Morphine, Oxycodone)", color: C.red, use: "Refractory/palliative dyspnea — ↓ air hunger", note: "20mg SR morphine/day effective in some COPD patients (BEAMS trial); individualize" },
    { drug: "Anxiolytics", sub: "(Benzodiazepines)", color: C.sub, use: "Hyperventilation syndrome, anxiety-driven dyspnea", note: "No consistent benefit in RCTs for dyspnea alone; use cautiously" },
  ];

  drugs.forEach((d, i) => {
    const y = 0.93 + i * 0.76;
    s.addShape(pres.ShapeType.rect, { x: 0.3, y, w: 0.09, h: 0.55, fill: { color: d.color }, line: { color: d.color } });
    s.addText(d.drug, { x: 0.55, y: y+0.03, w: 3.8, h: 0.28, fontSize: 11.5, bold: true, color: C.navy, margin: 0 });
    s.addText(d.sub, { x: 0.55, y: y+0.3, w: 3.8, h: 0.22, fontSize: 9, color: C.sub, italic: true, margin: 0 });
    s.addText(d.use, { x: 4.5, y: y+0.03, w: 5.3, h: 0.28, fontSize: 10.5, color: C.text, margin: 0 });
    s.addText(`• ${d.note}`, { x: 4.5, y: y+0.31, w: 5.3, h: 0.22, fontSize: 9, color: C.sub, margin: 0 });
    if (i < drugs.length - 1) {
      s.addShape(pres.ShapeType.rect, { x: 0.3, y: y+0.6, w: 9.4, h: 0.02, fill: { color: C.mid }, line: { color: C.mid } });
    }
  });

  footerNote(s, "Harrison's 22e | Murray & Nadel's | Smallwood et al. Eur Respir Rev 2024 (PMID 39384304)");
  slideNum(s, 7);
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 8 - QUALITY-BASED SYMPTOMATIC TREATMENT TABLE
// ═══════════════════════════════════════════════════════════════════
{
  const s = pres.addSlide();
  lightSlide(s);
  accentBar(s, 0, 0.09);

  bodyTitle(s, "Matching Treatment to Dyspnea Quality");
  divider(s, 0.82);

  sectionHeader(s, "Murray & Nadel's Table 36.3 — Physiology-Guided Symptomatic Treatment", 0.87);

  const rows = [
    { quality: "Air hunger / urge to breathe", physiology: "Chemoreceptor stimulation", treatment: "Supplemental O₂ · Nasal gas flow · Cool air fan · Opioids" },
    { quality: "Chest tightness", physiology: "Airway receptor stimulation", treatment: "Inhaled bronchodilators (β-agonists, anticholinergics, steroids)" },
    { quality: "Cannot get a deep breath", physiology: "Dynamic hyperinflation", treatment: "Pursed-lip breathing · Slow breathing retraining" },
    { quality: "Increased work / effort of breathing", physiology: "Mechanical load or neuromuscular weakness", treatment: "Inspiratory muscle training · NIV / BiPAP" },
    { quality: "Breathing more / rapidly", physiology: "Deconditioning · metaboreceptor stimulation", treatment: "Exercise training · Pulmonary rehabilitation" },
    { quality: "All qualities", physiology: "Altered central perception", treatment: "Pulmonary rehab desensitization · Morphine" },
  ];

  // Header row
  const headers = ["Quality of Dyspnea", "Physiology", "Symptomatic Treatment"];
  const colW = [2.85, 2.9, 3.85];
  const colX = [0.25, 3.12, 6.04];

  headers.forEach((h, i) => {
    s.addShape(pres.ShapeType.rect, { x: colX[i], y: 1.28, w: colW[i], h: 0.38, fill: { color: C.navy }, line: { color: C.navy } });
    s.addText(h, { x: colX[i]+0.05, y: 1.28, w: colW[i]-0.1, h: 0.38, fontSize: 9.5, bold: true, color: C.white, valign: "middle", margin: 0 });
  });

  rows.forEach((row, i) => {
    const y = 1.66 + i * 0.6;
    const bg = i % 2 === 0 ? C.white : C.light;
    const cells = [row.quality, row.physiology, row.treatment];
    cells.forEach((cell, j) => {
      s.addShape(pres.ShapeType.rect, { x: colX[j], y, w: colW[j], h: 0.58, fill: { color: bg }, line: { color: C.mid, pt: 0.5 } });
      s.addText(cell, { x: colX[j]+0.06, y: y+0.02, w: colW[j]-0.1, h: 0.54, fontSize: 9, color: j === 2 ? C.teal : C.text, valign: "middle", margin: 0, bold: j === 0 });
    });
  });

  footerNote(s, "Murray & Nadel's Textbook of Respiratory Medicine, 2-Volume — Table 36.3");
  slideNum(s, 8);
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 9 - PALLIATIVE / END-STAGE DYSPNEA
// ═══════════════════════════════════════════════════════════════════
{
  const s = pres.addSlide();
  lightSlide(s);
  accentBar(s, 0, 0.09);

  bodyTitle(s, "Dyspnea in End-Stage & Palliative Care");
  divider(s, 0.82);

  // Left column
  s.addShape(pres.ShapeType.rect, { x: 0.3, y: 0.95, w: 4.6, h: 4.0, fill: { color: "EAF4F7" }, line: { color: C.mid, pt: 1 } });
  s.addShape(pres.ShapeType.rect, { x: 0.3, y: 0.95, w: 4.6, h: 0.42, fill: { color: C.navy }, line: { color: C.navy } });
  s.addText("OPIOIDS — Mainstay of Palliation", { x: 0.4, y: 0.97, w: 4.4, h: 0.38, fontSize: 10.5, bold: true, color: C.white, valign: "middle", margin: 0 });
  s.addText([
    { text: "Mechanism: ↓ respiratory drive + cortical modulation of air hunger\n", options: { italic: true } },
    { text: "\n• Morphine (low dose oral/SC): most studied agent\n", options: {} },
    { text: "• 20 mg SR morphine/day significantly improved dyspnea in COPD crossover RCT\n", options: {} },
    { text: "• No association with ↑ hospitalization or mortality in ILD\n", options: {} },
    { text: "• BEAMS trial (JAMA 2022): mixed results in COPD — individualize\n", options: {} },
    { text: "• In acute asthma/COPD: small dose breaks tachypnea → hyperinflation cycle\n", options: {} },
    { text: "\n⚠ Risk: respiratory depression — use lowest effective dose", options: { bold: true, color: C.red } },
  ], { x: 0.45, y: 1.43, w: 4.35, h: 3.38, fontSize: 9.5, color: C.text, lineSpacingMultiple: 1.35 });

  // Right column
  s.addShape(pres.ShapeType.rect, { x: 5.1, y: 0.95, w: 4.6, h: 4.0, fill: { color: "EAF4F7" }, line: { color: C.mid, pt: 1 } });
  s.addShape(pres.ShapeType.rect, { x: 5.1, y: 0.95, w: 4.6, h: 0.42, fill: { color: C.teal }, line: { color: C.teal } });
  s.addText("Other Palliative Strategies", { x: 5.2, y: 0.97, w: 4.4, h: 0.38, fontSize: 10.5, bold: true, color: C.white, valign: "middle", margin: 0 });
  s.addText([
    { text: "Non-Pharmacologic:\n", options: { bold: true } },
    { text: "• Fan / cool air on face\n• Upright positioning\n• Anxiety management + CBT\n• Acupuncture (evidence in lung cancer & COPD)\n\n", options: {} },
    { text: "Anxiolytics:\n", options: { bold: true } },
    { text: "• No consistent RCT benefit for dyspnea alone\n• Trend toward benefit when combined with opioids\n• Appropriate for anxiety-driven/hyperventilation dyspnea\n\n", options: {} },
    { text: "Coordination of Care:\n", options: { bold: true } },
    { text: "• Pulmonology + Palliative care collaboration\n• Improves breathlessness mastery\n• Associated with prolonged survival", options: {} },
  ], { x: 5.18, y: 1.43, w: 4.35, h: 3.38, fontSize: 9.5, color: C.text, lineSpacingMultiple: 1.3 });

  footerNote(s, "Murray & Nadel's p.862-863 | Miller's Anesthesia 10e | Smallwood et al. Eur Respir Rev 2024");
  slideNum(s, 9);
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 10 - SUMMARY TABLE
// ═══════════════════════════════════════════════════════════════════
{
  const s = pres.addSlide();
  lightSlide(s);
  accentBar(s, 0, 0.09);

  bodyTitle(s, "Treatment Summary");
  divider(s, 0.82);

  const tableRows = [
    { tx: "Treat underlying cause", ev: "★★★★★", best: "All dyspnea" },
    { tx: "Supplemental O₂ (SpO₂ < 88%)", ev: "★★★★", best: "Hypoxemic patients" },
    { tx: "Short-acting bronchodilators", ev: "★★★★★", best: "Asthma, COPD exacerbation" },
    { tx: "IV Diuretics", ev: "★★★★★", best: "Acute decompensated heart failure" },
    { tx: "NIV / BiPAP", ev: "★★★★", best: "Acute hypercapnic/hypoxemic respiratory failure" },
    { tx: "Pulmonary rehabilitation", ev: "★★★★", best: "Chronic COPD, post-COVID" },
    { tx: "Low-dose opioids", ev: "★★★", best: "Refractory / palliative dyspnea" },
    { tx: "Fan / cool air", ev: "★★★", best: "Any dyspnea — simple adjunct" },
    { tx: "Pursed-lip / breathing retraining", ev: "★★★", best: "COPD, hyperventilation syndrome" },
    { tx: "Anxiolytics", ev: "★★", best: "Anxiety-driven / hyperventilation dyspnea" },
  ];

  const headers = ["Treatment", "Evidence", "Best For"];
  const colW2 = [3.6, 1.3, 4.7];
  const colX2 = [0.25, 3.87, 5.19];

  headers.forEach((h, i) => {
    s.addShape(pres.ShapeType.rect, { x: colX2[i], y: 0.92, w: colW2[i], h: 0.36, fill: { color: C.navy }, line: { color: C.navy } });
    s.addText(h, { x: colX2[i]+0.06, y: 0.92, w: colW2[i]-0.1, h: 0.36, fontSize: 10, bold: true, color: C.white, valign: "middle", margin: 0 });
  });

  tableRows.forEach((row, i) => {
    const y = 1.28 + i * 0.41;
    const bg = i % 2 === 0 ? C.white : C.light;
    const cells = [row.tx, row.ev, row.best];
    const evColor = row.ev.length >= 5 ? C.green : row.ev.length >= 4 ? C.teal : row.ev.length >= 3 ? C.amber : C.red;
    cells.forEach((cell, j) => {
      s.addShape(pres.ShapeType.rect, { x: colX2[j], y, w: colW2[j], h: 0.39, fill: { color: bg }, line: { color: C.mid, pt: 0.5 } });
      s.addText(cell, {
        x: colX2[j]+0.06, y: y+0.02, w: colW2[j]-0.1, h: 0.35,
        fontSize: j === 1 ? 11 : 9.5,
        color: j === 1 ? evColor : j === 0 ? C.navy : C.text,
        bold: j === 0,
        valign: "middle", margin: 0,
      });
    });
  });

  footerNote(s, "Harrison's 22e | Murray & Nadel's | Goldman-Cecil Medicine | Miller's Anesthesia 10e");
  slideNum(s, 10);
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 11 - CONCLUSION / KEY POINTS
// ═══════════════════════════════════════════════════════════════════
{
  const s = pres.addSlide();
  darkSlide(s);
  s.addShape(pres.ShapeType.rect, { x: 0, y: 5.2, w: 10, h: 0.425, fill: { color: C.teal }, line: { color: C.teal } });
  s.addShape(pres.ShapeType.rect, { x: 0, y: 0, w: 0.18, h: 5.625, fill: { color: C.teal }, line: { color: C.teal } });

  s.addText("KEY TAKEAWAYS", { x: 0.5, y: 0.2, w: 9, h: 0.4, fontSize: 13, bold: true, color: C.sky, charSpacing: 3, margin: 0 });
  s.addText("Treatment of Shortness of Breath", { x: 0.5, y: 0.6, w: 9, h: 0.65, fontSize: 28, bold: true, color: C.white, margin: 0 });

  const points = [
    "Always identify and treat the UNDERLYING CAUSE first — this is the most effective intervention.",
    "Give supplemental O₂ when SpO₂ < 88%; it also improves mortality in hypoxemic COPD.",
    "For obstructive lung disease: short-acting bronchodilators (SABA + SAMA) are the first-line acute treatment.",
    "Pulmonary rehabilitation reduces dyspnea, improves exercise capacity, and improves quality of life in COPD.",
    "Low-dose opioids (morphine) are evidence-backed for refractory and palliative dyspnea — individualize use.",
    "Cool air on the face (fan) is a simple, underused intervention that can meaningfully relieve air hunger.",
    "Anxiolytics have NOT shown consistent benefit for dyspnea in RCTs — use only for anxiety-driven cases.",
    "In end-stage lung disease, coordinate pulmonology + palliative care for best symptom mastery outcomes.",
  ];

  points.forEach((pt, i) => {
    const y = 1.42 + i * 0.49;
    s.addShape(pres.ShapeType.rect, { x: 0.4, y: y+0.08, w: 0.08, h: 0.08, fill: { color: C.sky }, line: { color: C.sky } });
    s.addText(pt, { x: 0.65, y, w: 9.0, h: 0.46, fontSize: 10.5, color: C.mid, lineSpacingMultiple: 1.1, margin: 0, valign: "middle" });
  });

  s.addText("Sources: Harrison's 22e · Murray & Nadel's · Goldman-Cecil · Miller's Anesthesia 10e · Smallwood et al. Eur Respir Rev 2024", {
    x: 0.3, y: 5.25, w: 9.4, h: 0.2,
    fontSize: 7, color: C.white, margin: 0, italic: true,
  });
}

// ─── WRITE FILE ───────────────────────────────────────────────────
pres.writeFile({ fileName: "/home/daytona/workspace/dyspnea-slides/Dyspnea_Treatment.pptx" })
  .then(() => console.log("✅ Saved: /home/daytona/workspace/dyspnea-slides/Dyspnea_Treatment.pptx"))
  .catch(err => { console.error("❌ Error:", err); process.exit(1); });

Running Command

cd /home/daytona/workspace/dyspnea-slides && node create_slides.js

Running Command

ls -lh /home/daytona/workspace/dyspnea-slides/Dyspnea_Treatment.pptx

Your presentation is ready! Download it here:

Dyspnea Treatment

Presentation · PPTX

The deck contains 11 slides with a professional deep navy/teal medical theme:

Slide	Content
1	Title slide
2	What is Dyspnea? — definition, prevalence stats, 4 physiologic origins
3	Common Causes — 4 color-coded category cards (Cardiac, Pulmonary, Infective, Other)
4	Diagnostic Approach — 4-step flow (History → Exam → Investigations → Identify Cause)
5	Treatment Framework — two-goal split (Treat Cause vs. Relieve Symptom)
6	Non-Pharmacologic Treatments — 6 cards (O₂, Pulm Rehab, Breathing techniques, Fan, NIV, Procedures)
7	Pharmacologic Treatments — row-by-row drug reference with evidence notes
8	Quality-Based Treatment Table (Murray & Nadel's Table 36.3)
9	Palliative/End-Stage Dyspnea — opioids vs. other strategies
10	Summary Table with star-rated evidence levels
11	Key Takeaways (dark closing slide)

This is a shared conversation. Sign in to Orris to start your own chat.